PR90873

FREMONT, Calif. July 27, 2021 /PRNewswire=KYODO JBN/

Further validation of ability to deliver continuous remote patient vital signs

monitoring within both hospital and home settings.

LifeSignals Inc., today announced it has received FDA Class II 510 (k) approval

for the LifeSignals LX1550 Multiparameter Remote Monitoring Platform. This

follows recent CE marking and is further validation of LifeSignals' drive to

create innovative wireless platforms which can be used by clinicians for the

continuous collection of patient physiological data at home and in healthcare

settings.

Central to the platform is a single-use wearable multiparameter biosensor that

records Electrocardiography (2-channel ECG), Heart Rate, Respiration Rate, Skin

Temperature and Body Posture data for up to five days. The encrypted

physiological data can then be transmitted with high reliability from the

biosensor, via a relay app to a secure cloud-based platform. Clinicians and

Care Providers can access the cloud-based remote monitoring dashboard to view

patient physiological data and manage alert settings.

The Remote Monitoring Platform is designed to enable healthtech companies to

rapidly enhance their product and service portfolios to provide vital sign

monitoring to the widest possible patient base, from any location. The relay

app and dashboard are developer-friendly with ready-to-deploy software

development kit APIs and is suitable for large scale implementation.

"COVID-19 has broken down the barriers to remote patient monitoring globally

and I am proud of how the LifeSignals team has responded to develop the

Platform in such a short space of time," says Surendar Magar, Founder and CEO.

"This FDA 510 (k) approval marks another major milestone in the company's

development and mission. It has already been implemented successfully in

hospitals for monitoring COVID-19 patients in India and is being rolled out in

Europe, UK, Singapore and the Philippines. Our focus now is to rapidly

introduce low-cost remote vital sign monitoring to US healthtech companies

looking to expand their services and improve patient care."

www.lifesignals.com

Photo - https://mma.prnewswire.com/media/1582121/LifeSignals.jpg

SOURCE: LifeSignals Inc